-
2023
-
Tzield drug that can delay onset of type 1 diabetes has a pricetag close to $200,000
-
FDA Approves Second Interchangeable Insulin Product, Rezvoglar (insulin glargine-aglr)
-
Regeneron, CytomX announce bispecific therapeutics for cancer collab
-
Anti-Amyloid-ß Oligomer Antibody ACU193 Gains FDA Fast Track Designation
-
Nona and Dragonfly enter HCAb-based drug discovery partnership
-
FDA Grants Breakthrough Therapy Status to Iveric Bio’s Zimura for AMD
-
Diagnostic marker found for deadly brain disease marked by dementia, movement problems. Discovery could accelerate progress toward therapies for primary tauopathies
-
Biovac and IVI enter deal to develop oral cholera vaccine
-
New CRISPR-based tool inserts large DNA sequences at desired sites in cells
-
EC grants approval for AbbVie’s Skyrizi to treat Crohn’s disease